Immunogenicity and Tolerability of Broad Spectrum Human Papillomavirus (HPV) Vaccine in Adult and Young Adult Women (V503-004)
Clinical trial NCT03158220 · COMPLETED
Trial details
- NCT number
- NCT03158220
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-09-20
- Primary completion
- 2018-11-19
- Enrollment
- 1212
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.